Rezolute, Inc. (RZLT)
4.02
+0.15
(+3.88%)
USD |
NASDAQ |
Nov 10, 16:00
4.015
0.00 (0.00%)
After-Hours: 20:00
Rezolute Market Cap : 388.82M for Nov. 10, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 10, 2026 | 388.82M |
| November 09, 2026 | 374.32M |
| November 06, 2026 | 375.28M |
| November 05, 2026 | 352.07M |
| November 04, 2026 | 383.02M |
| November 03, 2026 | 387.86M |
| November 02, 2026 | 374.06M |
| October 30, 2026 | 380.80M |
| October 29, 2026 | 397.19M |
| October 28, 2026 | 406.83M |
| October 27, 2026 | 396.23M |
| October 26, 2026 | 368.27M |
| October 23, 2026 | 371.65M |
| October 22, 2026 | 372.13M |
| October 21, 2026 | 356.70M |
| October 20, 2026 | 356.70M |
| October 19, 2026 | 356.70M |
| October 16, 2026 | 345.13M |
| October 15, 2026 | 375.98M |
| October 14, 2026 | 407.80M |
| October 13, 2026 | 444.43M |
| October 12, 2026 | 469.50M |
| October 09, 2026 | 469.50M |
| October 08, 2026 | 447.32M |
| October 07, 2026 | 422.26M |
| Date | Value |
|---|---|
| October 06, 2026 | 416.47M |
| October 05, 2026 | 417.44M |
| October 02, 2026 | 386.59M |
| October 01, 2026 | 392.37M |
| September 30, 2026 | 399.12M |
| September 29, 2026 | 394.30M |
| September 28, 2026 | 402.98M |
| September 25, 2026 | 375.98M |
| September 24, 2026 | 379.84M |
| September 23, 2026 | 385.62M |
| September 22, 2026 | 389.48M |
| September 21, 2026 | 376.95M |
| September 18, 2026 | 369.76M |
| September 17, 2026 | 380.35M |
| September 16, 2026 | 383.24M |
| September 15, 2026 | 399.61M |
| September 14, 2026 | 409.24M |
| September 11, 2026 | 406.35M |
| September 10, 2026 | 401.54M |
| September 09, 2026 | 390.95M |
| September 08, 2026 | 423.69M |
| September 04, 2026 | 441.02M |
| September 03, 2026 | 437.17M |
| September 02, 2026 | 439.09M |
| September 01, 2026 | 433.32M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Opus Genetics, Inc. | 349.60M |
| ACADIA Pharmaceuticals, Inc. | 3.159B |
| Alnylam Pharmaceuticals, Inc. | 20.30B |
| Anika Therapeutics, Inc. | 180.42M |
| Savara, Inc. | 1.011B |
Market Cap Related Metrics
| Price to Book Value | 4.524 |
| Price | 4.02 |
| Earnings Yield | -18.59% |